Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution.
In the perioperative period, artificial colloids are most often infused in doses of 500-1000 mL intravenously. This randomized study compared the effects on intravascular volume and coagulation of approximately 2000 mL of two isooncotic artificial colloids: 6% hydroxyethyl starch (HES; MW 200,000; substitution ratio 0.40-0.55) and 3% modified fluid gelatin (GEL). We hypothesized more pronounced hypocoagulation with HES and a weaker intravascular volume effect of GEL. Forty-two patients, scheduled for primary total hip replacement, were allocated randomly to receive HES or GEL during acute normovolemic hemodilution and subsequent further intraoperative hemodilution. Blood samples were taken before and after 500 mL and 1000 mL of acute normovolemic hemodilution; intraoperatively after 20 mL/kg of artificial colloid and at the end of colloid infusion; on arrival in the recovery room; and 3 h later. We quantified: 1) coagulation variables; 2) blood loss; 3) hemodynamic stability; 4) necessary infusion volume; 5) interstitial extravasation, calculated from plasma volunteers measured using albumin marked with technetium-99m and iodine-125, respectively; 6) percentage volume effect at the end of the study as well as hematocrit, total serum protein, and colloid osmotic pressure. Intraoperative volume therapy was guided by radial systolic pressure and systolic pressure variation, mixed venous hemoglobin saturation in the pulmonary artery, and pulmonary capillary occlusion pressure.(ABSTRACT TRUNCATED AT 250 WORDS)
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000418:Albumins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D016063:Blood Loss, Surgical; D001794:Blood Pressure; D001798:Blood Proteins / Q000032:analysis; D001810:Blood Volume / Q000187:drug effects*; D003102:Colloids / Q000627:therapeutic use; D005110:Extracellular Space / Q000378:metabolism; D005440:Fluid Therapy; D005780:Gelatin / Q000627:therapeutic use*; D006400:Hematocrit; D006438:Hemodilution; D006622:Hip Prosthesis; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D007430:Intraoperative Care; D007457:Iodine Radioisotopes; D008875:Middle Aged; D010952:Plasma Substitutes / Q000627:therapeutic use*; D010953:Plasma Volume; D013667:Technetium; D013997:Time Factors
D000418:Albumins; D001798:Blood Proteins; D003102:Colloids; D006895:Hydroxyethyl Starch Derivatives; D007457:Iodine Radioisotopes; D010952:Plasma Substitutes; D013667:Technetium; D005780:Gelatin